$0.252900
-0.02-5.85%
At Close: -
$0.255200
0.00230.91%
After Hours: 5:51 PM EDT
15 minutes delayed
60 Degrees
SXTPNASDAQ
Latest news for 60 Degrees (NASDAQ:SXTP) Stock
60 Degrees Stock (NASDAQ: SXTP)
Categories: All
Thursday, June 27, 2024
Tuesday, June 11, 2024
Thursday, June 06, 2024
Thursday, May 30, 2024
Tuesday, May 28, 2024
Friday, May 24, 2024
Wednesday, May 15, 2024
Monday, May 13, 2024
Wednesday, May 08, 2024
Thursday, May 02, 2024
Wednesday, April 03, 2024
Tuesday, April 02, 2024
Tuesday, March 26, 2024
Thursday, March 14, 2024
Tuesday, February 20, 2024
Friday, February 02, 2024
Tuesday, January 30, 2024
- Nasdaq Tumbles Over 100 Points; GM Shares Gain On Earnings Beat
- Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Crude Oil Gains 1%; JetBlue Shares Fall After Q4 Results
- US Stocks Edge Lower; Pfizer Reports Surprise Profit
- 60 Degrees Pharmaceuticals shares are trading...
- 60 Degrees Pharmaceuticals Prices 5,260,901 U...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Monday, January 29, 2024
Monday, January 22, 2024
- 60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug
- 60 Degrees Pharma shares are trading higher a...
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- 60 Degrees Pharmaceuticals Announced That Fol...
Thursday, January 18, 2024
Tuesday, January 16, 2024
Thursday, January 11, 2024
Tuesday, December 26, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today?
- 60 Degrees Pharmaceuticals shares are trading...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 60 Degrees Pharma Announces IRB Approval Of Phase IIA Study To Evaluate Tafenoquine For Babesiosis, An Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled By FDA To January 17, 2024